290 related articles for article (PubMed ID: 30119201)
1. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
[TBL] [Abstract][Full Text] [Related]
3. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
[TBL] [Abstract][Full Text] [Related]
4. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway.
Wang J; Zhang Y; Liu X; Wang J; Li B; Liu Y; Wang J
Int J Mol Med; 2019 Sep; 44(3):1026-1038. PubMed ID: 31524219
[TBL] [Abstract][Full Text] [Related]
5. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
[TBL] [Abstract][Full Text] [Related]
6. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
[TBL] [Abstract][Full Text] [Related]
7. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
Lin Y; Peng N; Li J; Zhuang H; Hua ZC
Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
[TBL] [Abstract][Full Text] [Related]
8. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
[TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
12. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
Dai H; Jiang Y; Luo Y; Bie P; Chen Z
Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells.
Ho JN; Byun SS; Lee S; Oh JJ; Hong SK; Lee SE; Yeon JS
J Urol; 2015 Mar; 193(3):1016-22. PubMed ID: 25229559
[TBL] [Abstract][Full Text] [Related]
14. Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression.
Wang W; Li X; Sun W; Zhang L; Zhang M; Hong B; Lv G
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1597-605. PubMed ID: 22581262
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway.
He S; Chen M; Lin X; Lv Z; Liang R; Huang L
Eur J Pharmacol; 2020 Jan; 867():172811. PubMed ID: 31756335
[TBL] [Abstract][Full Text] [Related]
16. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
[TBL] [Abstract][Full Text] [Related]
17. Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
Takeuchi H; Mmeje CO; Jinesh GG; Taoka R; Kamat AM
Oncol Rep; 2015 Nov; 34(5):2738-44. PubMed ID: 26323344
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.
Yao C; Li H; Zhang W
Int J Immunopathol Pharmacol; 2018; 32():2058738418812349. PubMed ID: 30453799
[TBL] [Abstract][Full Text] [Related]
19. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
Gao X; Liu J; Fan D; Li X; Fang Z; Yan K; Fan Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935059
[TBL] [Abstract][Full Text] [Related]
20. Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer.
Zhu W; Li J; Wu S; Li S; Le L; Su X; Qiu P; Hu H; Yan G
Pancreas; 2012 Oct; 41(7):1029-38. PubMed ID: 22617708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]